humanigen.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.humanigen.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Humanigen,
Description The Cytokine Storm We are a clinical stage biopharmaceutical company, developing our immunology and immuno-oncology portfolio of monoclonal
Keywords N/A
Server Information
WebSite humanigen faviconhumanigen.com
Host IP 23.236.62.147
Location United States
Related Websites
Site Rank
More to Explore
humanigen.com Valuation
US$41,400,890
Last updated: 2023-05-03 17:00:29

humanigen.com has Semrush global rank of 255,654. humanigen.com has an estimated worth of US$ 41,400,890, based on its estimated Ads revenue. humanigen.com receives approximately 4,777,026 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, humanigen.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$41,400,890
Daily Ads Revenue US$38,217
Monthly Ads Revenue US$1,146,487
Yearly Ads Revenue US$13,757,835
Daily Unique Visitors 318,469
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
humanigen.com. A 600 IP: 23.236.62.147
humanigen.com. NS 3600 NS Record: ns68.domaincontrol.com.
humanigen.com. NS 3600 NS Record: ns67.domaincontrol.com.
humanigen.com. MX 600 MX Record: 10 us-smtp-inbound-1.mimecast.com.
humanigen.com. MX 600 MX Record: 10 us-smtp-inbound-2.mimecast.com.
humanigen.com. TXT 600 TXT Record: MS=ms50102227
humanigen.com. TXT 600 TXT Record: 2320814
humanigen.com. TXT 600 TXT Record: v=spf1 include:_netblocks.mimecast.com ~all
humanigen.com. TXT 600 TXT Record: google-site-verification=AvNn0KIMDFIF69OXgwn_ZgpaCcz5_0u6tq5_U-H6ii4
HtmlToTextCheckTime:2023-05-03 17:00:29
top of page Humanigen Logo About Humanigen Our Team Business Development Informational Videos Media Resources Contact Us Subsidiaries Compassionate Use Publications COVID-19 CAR-T/CRS CMML aGvHD ifabotuzumab HGEN005 COVID-19 KOL Videos Cytokine Storm Investor Relations Overview News Events & Presentations Stock Info SEC Filings Governance Humanigen, Inc. The Cytokine Storm Company Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), is a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’. Lenzilumab is a first-in class antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). Results from preclinical models indicate GM-CSF is an upstream regulator of many inflammatory cytokines and chemokines involved in the cytokine storm. Early in the COVID-19 pandemic, investigation showed high levels of GM-CSF secreting T cells were associated with disease severity and intensive care unit
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Mon, 25 Oct 2021 22:02:20 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.humanigen.com/
strict-transport-security: max-age=120
Age: 24405
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=96
X-Seen-By: jeslxIFvDH4ulYwNNi+3MiWfEJXUOf1J0Ah0dFlolkk=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVjeN/0e8uL/f+QjgQRA5x3g,m0j2EEknGIVUW/liY8BLLofPMFlPr4bYuP+4pIJqPkgXK4CpcIIKXm19QkScmIm+,2d58ifebGbosy5xc+FRalt1sDWCyb/ePNbkDWujd1xUHEith5K5pic75d9/Cj0Ywb6EZodlxSfsWbnW8estcAw==,2UNV7KOq4oGjA5+PKsX47Acb9tPMRl4SW2bhgA9BBDtYgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1635199340.77511237876014912523
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Mon, 25 Oct 2021 22:02:21 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1635199340.933340873697519578
set-cookie: hs=2061182189; Max-Age=-1; Expires=Mon, 25 Oct 2021 22:02:20 GMT; Path=/; Domain=www.humanigen.com; HTTPOnly
set-cookie: svSession=051199bc447ee509f464d0c2eb4560ea27396480e0d2bb9cc073dd7c14765a4a08d30e51877ba9384bfa69c4693d75fc1e60994d53964e647acf431e4f798bcdfed181a921664c4da7afa1906fd1d35f1d527aa81c496233c714e661c436e87458b2c23d0e18b1648b4a79b889bed6d0c72f7d9e38f5870f339b2492f21aa807d6209b6e3ae326082a47620660b8b8bf; Max-Age=63071999; Expires=Wed, 25 Oct 2023 22:02:20 GMT; Path=/; Domain=www.humanigen.com; Secure; HTTPOnly; SameSite=None
vary: Accept-Encoding
cache-control: no-cache
content-language: en
strict-transport-security: max-age=120
set-cookie: XSRF-TOKEN=1635199341|YjJArH3ebCj1; Path=/; Domain=www.humanigen.com; Secure; SameSite=None
age: 0
set-cookie: ssr-caching=cache#desc=none; Max-Age=20; Expires=Mon, 25 Oct 2021 22:02:41 GMT
server-timing: cache;desc=none
x-seen-by: wmgbEcS9zOENaefw7bU4YQ8Y66LJDNaBMsqwxsoJKXk=,jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVho24eAEbfscWhcpKw1HIzZ,m0j2EEknGIVUW/liY8BLLnA6bACTJOyhQFe80epZkoEa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalqR4uoSoe2myVTYx6LPgdixr3V5T2aRG/Jlz5AADXnGbXuu4K7JOGC7jsQYS0hcDAw==,2UNV7KOq4oGjA5+PKsX47DqQgZ4euQCNWDy58PBtjlYfbJaKSXYQ/lskq2jK6SGP,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,iNzairCM74Jm+18Ga2HaNTiTwefvWf/NbsSqzAU9RH1Gp/J3MBzgzU8QHrQuh4zQ,UvY1uiXtmgas6aI2l+unv9Uv2BOyy0pTkc6JqglAy6B/emkIpglOPBlx/7qGCfCtSYblWJ1+I4NCiXX+q5JMPA==,iNzairCM74Jm+18Ga2HaNTiTwefvWf/NbsSqzAU9RH1Gp/J3MBzgzU8QHrQuh4zQ,qJS91GsscGZlb16v+8nwmI77owKHA5L0OSbRVxtr6utGp/J3MBzgzU8QHrQuh4zQ,LoUK8/saGAmOxZWtpubo2iTOnK3GmbK6QcBXwd5Fv/rOE3ENzmayOFpfiKgkjuz3pbiAKa22rkR9AuVa++dgTg==,qJS91GsscGZlb16v+8nwmI77owKHA5L0OSbRVxtr6utGp/J3MBzgzU8QHrQuh4zQ,8Jozq2XDr5/0Pv3E0yMnd4y2XGuTQF950VXOodQ5asFGp/J3MBzgzU8QHrQuh4zQ,/a5ccLSK1HEmwPNg/x6OuntjqKv6IMr0lqdQ/qxGlZVMN/0V2kCEmbdM+B6/pPYlfHhbBw6ikV3T9Iwn/cFdXA==
accept-ranges: bytes
set-cookie: _wixAB3|02a5068d-04c8-45d6-87b9-0997b4ecf4a5=175264#2|261436#2|232814#2|234222#1|136130#2|223497#1|150438#4|261413#2|205780#1|82045#1|218208#1|236860#1|15161#1|208619#1|277449#2|277552#1|202435#1|273366#2|194219#2|191715#2|272282#1|275276#1|270879#1|171893#2|211047#1|269779#2|97651#1|225455#2|200674#4|268709#1|185525#2|185798#1|203287#1|240333#2|182661#2|233548#1|272292#15|202922#2|271628#2|232564#2|261352#2|205715#1|277909#1|136022#1|210044#1|233617#2|277653#1|192788#2|261437#1|199602#1; Max-Age=3600; Expires=Mon, 25 Oct 2021 23:02:21 GMT; Domain=.wix.com
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131a216aa38b83f57f89913d4b5afc3e82e5df02fc372756cb2ecc9ff6724d16f33fe6bb275e82cb8256ab4e36b92412506; Path=/;SameSite=none;Secure
set-cookie: TS011cd3e8=01f0e93131a216aa38b83f57f89913d4b5afc3e82e5df02fc372756cb2ecc9ff6724d16f33fe6bb275e82cb8256ab4e36b92412506; path=/; domain=www.humanigen.com;SameSite=none;Secure
set-cookie: TS01de44c0=01f0e93131a216aa38b83f57f89913d4b5afc3e82e5df02fc372756cb2ecc9ff6724d16f33fe6bb275e82cb8256ab4e36b92412506; path=/; domain=.wix.com;SameSite=none;Secure
server: Pepyaka/1.15.10
humanigen.com Whois Information
Domain Name: HUMANIGEN.COM
Registry Domain ID: 2129439688_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-12-28T08:22:17Z
Creation Date: 2017-05-30T20:48:04Z
Registry Expiry Date: 2023-05-30T20:48:04Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS67.DOMAINCONTROL.COM
Name Server: NS68.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-14T00:08:49Z <<<

Copyright © 2022 WebZZ.US 0.0245